Literature DB >> 9302274

A novel phenotypic pattern in X-linked inheritance: craniofrontonasal syndrome maps to Xp22.

G J Feldman1, D E Ward, E Lajeunie-Renier, D Saavedra, N H Robin, V Proud, L J Robb, V Der Kaloustian, J C Carey, M M Cohen, V Cormier, A Munnich, E H Zackai, A O Wilkie, R A Price, M Muenke.   

Abstract

Craniofrontonasal syndrome (CFNS, OMIM 304110) is a distinctive genetic disorder whose main clinical manifestations include coronal synostosis, widely spaced eyes, clefting of the nasal tip and various skeletal anomalies. CFNS originally was thought to be transmitted as an autosomal dominant trait, but recent studies suggest that it is X-linked dominant, whereby all daughters of males are affected, whereas none of their sons are affected. Here we report data confirming that CFNS is X-linked, mapping to a 13 cM interval in Xp22 with a maximum two-point lod score of 3.9 (theta = 0) at DXS8022 and a multipoint lod score of 5.08 at DXS1224. Detailed phenotypic analysis shows that females are more severely affected than males, a highly unusual characteristic for an X-linked disorder. CFNS represents the first multiple congenital anomaly syndrome with this unusual phenotypic pattern of X-linked inheritance.

Entities:  

Mesh:

Year:  1997        PMID: 9302274     DOI: 10.1093/hmg/6.11.1937

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

Review 1.  Frontonasal Dysplasia: Towards an Understanding of Molecular and Developmental Aetiology.

Authors:  Peter G Farlie; Naomi L Baker; Patrick Yap; Tiong Y Tan
Journal:  Mol Syndromol       Date:  2016-10-29

2.  Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.

Authors:  Shih-hsin Kan; Navaratnam Elanko; David Johnson; Laura Cornejo-Roldan; Jackie Cook; Elsa W Reich; Susan Tomkins; Alain Verloes; Stephen R F Twigg; Sahan Rannan-Eliya; Donna M McDonald-McGinn; Elaine H Zackai; Steven A Wall; Maximilian Muenke; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2002-01-04       Impact factor: 11.025

3.  Additional EFNB1 mutations in craniofrontonasal syndrome.

Authors:  Deeann Wallis; Felicitas Lacbawan; Mahim Jain; Vazken M Der Kaloustian; Carlos E Steiner; John B Moeschler; H Wolfgang Losken; Ilkka I Kaitila; Stephen Cantrell; Virginia K Proud; John C Carey; Donald W Day; Dorit Lev; Ahmad S Teebi; Luther K Robinson; H Eugene Hoyme; Nadia Al-Torki; Jacqueline Siegel-Bartelt; John B Mulliken; Nathaniel H Robin; Dolores Saavedra; Elaine H Zackai; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

4.  Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome.

Authors:  Ilse Wieland; Sibylle Jakubiczka; Petra Muschke; Monika Cohen; Hannelore Thiele; Klaus L Gerlach; Ralf H Adams; Peter Wieacker
Journal:  Am J Hum Genet       Date:  2004-04-29       Impact factor: 11.025

5.  Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome.

Authors:  Stephen R F Twigg; Rui Kan; Christian Babbs; Elena G Bochukova; Stephen P Robertson; Steven A Wall; Gillian M Morriss-Kay; Andrew O M Wilkie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

6.  Identification and expression analysis of a novel intragenic EFNB1 mutation causing craniofrontonasal syndrome.

Authors:  Oscar F Chacon-Camacho; Rocio Arce-Gonzalez; Vanessa Villegas-Ruiz; Erika Pelcastre-Luna; Conrado E Uría-Gómez; Mariella Granillo-Alvarez; Juan C Zenteno
Journal:  Meta Gene       Date:  2013-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.